|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,047 KRW | -0.95% |
|
-6.85% | -37.75% |
| 2023 | Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding | CI |
| 2023 | Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding | CI |
Kyung Nam Pharm Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 291.54 million compared to KRW 311.52 million a year ago. Net loss was KRW 107.36 million compared to KRW 2,999.06 million a year ago.
Basic loss per share from continuing operations was KRW 3 compared to KRW 137 a year ago. Basic loss per share was KRW 3 compared to KRW 137 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -37.75% | 26.79M | |
| +19.46% | 43.29B | |
| +27.79% | 22.38B | |
| +19.29% | 15.51B | |
| +19.55% | 14.52B | |
| +56.57% | 12.93B | |
| -0.05% | 6.79B | |
| -11.69% | 6.56B | |
| +17.73% | 5.87B | |
| -8.87% | 5.73B |
KYUNG NAM PHARM CO.,LTD. 
